Congratulations to Jess Wu for successfully completing her Ph.D. qualification exam. Jess is now a Ph.D. Candidate!
Jess’ research will focus on the anti-angiogenic compound, thrombospondin-1 (TSP1). She will be construct experimentally-validated computational models to study TSP1 signaling and predict optimal anti-angiogenic therapies. This builds on her 2017 paper of TSP1 signaling through the CD36 receptor published in Cell Communication and Signaling.
We look forward to Jess’ impactful research!